Ideaya Biosciences Inc. (IDYA) at a glance

Ideaya Biosciences Inc. (IDYA) is a mid-cap Healthcare company. It trades at $37.59, with a -62.2% profit margin and revenue decline of 39.7%. It does not pay a dividend. Vestovix scores it 42/100 overall. Its strongest dimension is Momentum (67/100) and its weakest is Growth (12/100). It is a relatively defensive holding with below-market volatility.

Price

$37.59

Market cap

$2.74B

P/E ratio

n/a

Dividend yield

None

Beta

-0.05

52-week range

$23.23 to $42.68